About_Us

Established in 2024, ProCyl Therapeutic stands as an anchor of possibility in the battle against cancer and infectious diseases, employing innovative approaches to drug discovery and development. Founded on the core principle of “we care, we cure,” our primary mission is to discover and deliver effective treatments for cancer and neglected diseases that continue to afflict millions worldwide, including those with a more localized impact in India. Our vision is in perfect alignment with the “Make in India” initiative, as we aspire to pioneer groundbreaking therapies developed right here within the nation’s borders.

With a wealth of experience in drug discovery and pharmaceutics, our team specializes in microbiology, bio-analytics, and small molecule synthesis. Drawing upon this deep expertise, our goal is to introduce innovative therapeutics that has the potential to revolutionize healthcare. The founders of ProCyl Therapeutic are not only skilled professionals in research and development, but they also possess the entrepreneurship and financial understanding necessary to guide the company towards sustainable growth, even in the face of challenges.

Our focus spans multiple facets of drug discovery, including:

1. Small Molecule Synthesis and Characterization: We specialize in identifying and characterizing small molecules that show potential as therapeutic agents.
2. Expression and Purification of Recombinant Proteins: Our capabilities in producing and purifying recombinant proteins are crucial for assay development and structure-based drug discovery.
3. Generation of Genetically Modified Cell Lines: We develop cell lines to facilitate innovative and patient centric drug discovery processes.

The journey of ProCyl Therapeutics began with significant academic research from the founders resulting in patents, with our first granted patent in 2019 marking a milestone for IIT Gandhinagar. This achievement has propelled us to translate research, aiming to create tangible benefits for the society.

With a robust network of collaborators, we are poised to make significant strides in the domestic and international markets. Our dedication to quality and innovation drives us to provide cutting-edge treatments that are both effective and accessible. 

ProCyl Therapeutic envisions a future where our therapies save lives. By harnessing our expertise and resources, we strive to lead the way in oncology drug discovery and contribute to a healthier tomorrow.